Accolade, Inc.

NasdaqGS ACCD

Accolade, Inc. Net Income for the Trailing 12 Months (TTM) ending November 30, 2024: USD -180.30 M

Accolade, Inc. Net Income is USD -180.30 M for the Trailing 12 Months (TTM) ending November 30, 2024, a -46.90% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
  • Accolade, Inc. Net Income for the Trailing 12 Months (TTM) ending November 30, 2023 was USD -122.73 M, a 73.54% change year over year.
  • Accolade, Inc. Net Income for the Trailing 12 Months (TTM) ending November 30, 2022 was USD -463.77 M, a -397.11% change year over year.
  • Accolade, Inc. Net Income for the Trailing 12 Months (TTM) ending November 30, 2021 was USD -93.29 M, a -94.10% change year over year.
  • Accolade, Inc. Net Income for the Trailing 12 Months (TTM) ending November 30, 2020 was USD -48.06 M, a 14.44% change year over year.
Key data
Date Net Income EPS (Diluted) Shares (Diluted, Weighted) Net Income Margin
Market news
Loading...
NasdaqGS: ACCD

Accolade, Inc.

CEO Mr. Rajeev Singh
IPO Date July 1, 2020
Location United States
Headquarters 660 West Germantown Pike
Employees 2,400
Sector Health Care
Industries
Description

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

Similar companies

PRVA

Privia Health Group, Inc.

USD 21.00

1.25%

EVH

Evolent Health, Inc.

USD 11.18

-9.77%

NRC

National Research Corporation

USD 16.93

-1.97%

CERT

Certara, Inc.

USD 10.74

-2.10%

DH

Definitive Healthcare Corp.

USD 3.92

-0.25%

PHR

Phreesia, Inc.

USD 26.12

-1.69%

HSTM

HealthStream, Inc.

USD 31.47

1.68%

HCAT

Health Catalyst, Inc.

USD 5.90

-9.09%

PINC

Premier, Inc.

USD 21.46

0.61%

StockViz Staff

January 15, 2025

Any question? Send us an email